American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 907-915, November 2008

Safety of Ferumoxytol in Patients With Anemia and CKD

  • Ajay Singh, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Tejas Patel, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • ,
  • Joachim Hertel, MD

      Affiliations

    • University Hospital Medical Center, Augusta, GA
    • ,
  • Marializa Bernardo, MD

      Affiliations

    • Southwest Houston Research, Houston, TX
    • ,
  • Annamaria Kausz, MD

      Affiliations

    • AMAG Pharmaceuticals Inc, Cambridge, MA
    • Tufts University School of Medicine, Boston, MA
    • ,
  • Louis Brenner, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
    • AMAG Pharmaceuticals Inc, Cambridge, MA
    • Corresponding Author InformationAddress correspondence to Louis Brenner, MD, AMAG Pharmaceuticals Inc, 61 Mooney St, Cambridge, MA 02138

Received 11 March 2007; accepted 1 August 2008. published online 29 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Trial registration: www.clinicaltrials.gov; study number: NCT 00255450.

 Originally published online as doi:10.1053/j.ajkd.2008.08.001 on September 29, 2008.

PII: S0272-6386(08)01191-8

doi:10.1053/j.ajkd.2008.08.001

Refers to article:

  • Ferumoxytol as a New, Safer, Easier-to-Administer Intravenous Iron: Yes or No?

    Michael Auerbach
    American Journal of Kidney Diseases November 2008 (Vol. 52, Issue 5, Pages 826-829)

American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 907-915, November 2008

Article Tools

* Image Usage & Resolution